Company Analysis
Sign in

GeoVax Labs, Inc. (GOVX)

Nasdaq: GOVX · Pharmaceutical Preparations · Smyrna, GA · filing with the SEC since 1996
Full chart Alerts Compare
Grade4.4
◀ Past 2.1● Present 4.8▶ Future 5.5
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedApr 15, 2026Mar 27, 2025Feb 29, 2024Mar 23, 2023Mar 9, 2022Mar 23, 2021Mar 24, 2020Mar 26, 2019Mar 23, 2018Mar 24, 2017
Revenue2,489,1453,954,576081,526385,5011,823,6581,175,896963,2031,075,270828,918
Research and development18,121,51923,713,60220,720,7669,123,47915,554,1712,444,4591,910,7151,878,6522,017,3501,970,859
General and administrative6,006,6735,385,2546,022,1734,986,6113,577,1532,196,0141,637,6741,647,2681,232,3682,131,426
Total operating expenses24,128,19229,098,85626,742,93914,110,09019,131,3244,640,4733,548,3893,525,9203,249,7184,102,285
Operating income-21,639,047-25,144,280-26,742,939-14,028,564-18,745,823-2,816,815-2,372,493-2,562,717-2,174,448-3,273,367
Interest expense021,375001,286143,5244,4952,590··
Interest and investment income174,276173,359776,1777,4394,7362,2716,3595,2134,2861,666
Total non-operating income (expense)174,276151,984776,1777,439175,506-141,2531,8642,6234,2861,666
Income tax expense····000000
Net income-21,464,771-24,992,296-25,966,762-14,021,125-18,570,317-2,958,068-2,370,629-2,560,094-2,170,162-3,271,701
Earnings per share, basic-22.40-120.46r-357.25b-309.75rb-1,140.00b·····
Earnings per share, basic and diluted····-1,140.00b-802.50b-293,201.25rb-5,853,873.75rb-11.25b-30.00b
Weighted average shares, basic958,443207,482r72,691b45,262rb16,266b·····
Weighted average shares, basic and diluted····16,266b3,690b8rb0rb182,949b110,711b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-25 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton GOVX · research, not advice